Assignee
VASGENE THERAPEUTICS INC
US·5 granted patents·13 pending applications·29 citations·filing 2004–2022
Top patents by PatentIndex Score
18 records- 0183US7862816B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Jan 4, 2011·15 cites·13 claims
- 0279US7381410B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Jun 3, 2008·6 cites·34 claims
- 0378US7585967B2Nucleic acid compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2004·Granted Sep 8, 2009·8 cites·10 claims
- 0466US2010093831A1Nucleic acid compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 0565US2010261653A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 0660US9533026B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2013·Granted Jan 3, 2017·0 cites·7 claims
- 0758US2025123284A1Diagnostic methods for cancer using ephrinb2 expressionVASGENE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0858US2010330152A1Methods and compositons for antisense vegf oligonucleotidesVASGENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 0956US2011009323A1Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1055US2006204512A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1153US2011129482A1Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1248US7977463B2Polypeptide compounds for inhibiting angiogenesis and tumor growthVASGENE THERAPEUTICS INC·Filed 2005·Granted Jul 12, 2011·0 cites·31 claims
- 1348US2022249621A1TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINSVASGENE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1448US2006194220A1Compositions and methods for detecting and treating tumorsVASGENE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1545US2007218061A1Use of ephrinb2 directed agents for the treatment or prevention of viral infectionsVASGENE THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1645US2022153791A1Ephb4-ephrin b2 receptor ligand pair as a novel marker for the treatment of prostate cancerVASGENE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1742US2011213127A1Methods for using and identifying modulators of delta-like 4VASGENE THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 1838US2007213266A1Methods for using and identifying modulators of Delta-like 4VASGENE THERAPEUTICS INC·Filed 2006·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →